Rob DekkerVice President CMC at TargED BiopharamceuticalsSpeaker
Profile
Senior Leader in CMC (Chemistry, Manufacturing and Controls) with three decades of experience translating manufacturing science into compliant, scalable operations. Leads cross-functional programs and teams integrating process design, validation, and regulatory authoring and submissions from early IND/IMPD to MAA/BLA.
From 1 March 2026 Rob is VP CMC at TargED Biopharmaceuticals. Before joining TargED Rob worked for over 10 years as CMC Leader at Johnson & Johnson (J&J). Prior to J&J he worked in Leadership and Expert roles in CMC and GMP at TEVA, Kiadis Pharma (later Sanofi), Octoplus (now Delpharm), Biogen and DSM Biologics (now Thermo Fisher Scientific). His experience covers CMC development and GMP manufacturing of a wide range of pharmaceutical products and technologies, including small molecules, biomolecules, cell therapies and vaccines.
Agenda Sessions
Phase-Appropriate CMC: Balancing Scale, Efficiency, and Quality by Design throughout pharmaceutical development/towards commercialization
, 09:05View SessionPANEL DISCUSSION | Future-Proofing CMC Strategies for Complex/Emerging Modalities
, 16:30View SessionPANEL DISCUSSION | Future-Proofing CMC Strategies for Complex/Emerging Modalities
, 16:30View Session
